Advances in safety in the treatment of PCa (2021)

Pre-recording by Dr. Alan So (CUA)
Safety data – GNRH Analogues, focus on CVD risk profile
– PCa therapy induced CVD toxicity
– ADT plus newer antiandrogens
– Radiotherapy alone or in combination
– Data from latest trials – HERO

Pre-recording by Prof. Axel Merseburger (EAU)
Safety data – mHSPC therapy and CVD risk profile
– Data from animal models & basic research
– Other treatment modalities (chemotherapy, surgery, ADT alone or in combination)
– New treatment modalities and CVD toxicity

Live webinar
– Case study (incl. cardiac biomarkers) by Ass. Prof. Katie Zhang (ICOS)
– Q&A by panellists Dr. Alan So & Prof. Axel Merseburger

At a glance

Publication date: September, 2021
Available languages: English
Topic: Prostate cancer
CME: 1 European CME credits (ECMEC)
Duration: Approx. 60 – 90 minutes